Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first

Business Archived • July 22, 2026 • 7 views

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.

Source: https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=100003114 - Read Original

"Free Quote Today"

FB X ✉️

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!